Search clinical trials for: GW869682

Total 3 results

GlaxoSmithKline

Completed

Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs

Obesity | Diabetes Mellitus, Type 2

United Kingdom
GlaxoSmithKline

Completed

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

Obesity

United States
GlaxoSmithKline

Completed

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Non-Insulin-Dependent Diabetes Mellitus

Germany, United States

3

Subscribe